Article Versions Notes

Champion JD, Dodd KM, Lam HC, Alzahrani MAM, Seifan S, Rad E, Scourfield DO, Fishel ML, Calver BL, Ager A, et al. Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells. Cancers. 2022; 14(24):6195. https://doi.org/10.3390/cancers14246195

Champion, Jesse D., Kayleigh M. Dodd, Hilaire C. Lam, Mohammad A. M. Alzahrani, Sara Seifan, Ellie Rad, David Oliver Scourfield, Melissa L. Fishel, Brian L. Calver, Ann Ager, and et al. 2022. "Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells" Cancers 14, no. 24: 6195. https://doi.org/10.3390/cancers14246195

Champion, J. D., Dodd, K. M., Lam, H. C., Alzahrani, M. A. M., Seifan, S., Rad, E., Scourfield, D. O., Fishel, M. L., Calver, B. L., Ager, A., Henske, E. P., Davies, D. M., Kelley, M. R., & Tee, A. R. (2022). Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells. Cancers, 14(24), 6195. https://doi.org/10.3390/cancers14246195